Home > Healthcare > Biotechnology > Bioservices > Spatial OMICS Market

Spatial OMICS Market Size

  • Report ID: GMI9050
  • Published Date: Apr 2024
  • Report Format: PDF

Spatial OMICS Market Size

Spatial OMICS Market size was valued at USD 384.4 million in 2023 and is expected to exhibit growth at a CAGR of 14.3% from 2024 – 2032 period driven by increasing adoption of spatial genomics & transcriptomics and proteomics techniques in research and clinical applications.

 

The ability to analyze spatially resolved molecular information within tissues provides researchers with a deeper understanding of complex biological processes and disease mechanisms, leading to the development of more targeted therapies and precision medicine approaches. Additionally, advancements in technology, such as improved imaging modalities and high-throughput sequencing platforms, are driving the growth of the market by enabling more efficient and accurate analysis of spatially resolved molecular data. Furthermore, collaborations between academic research institutions, pharmaceutical companies, and biotechnology firms are fueling innovation in the field, driving further market expansion.
 

Spatial OMICS refers to a set of techniques that allow the study of biological molecules within their spatial context in tissues or cells. These techniques enable researchers to understand the spatial organization of molecules such as DNA, RNA, proteins, and metabolites, providing insights into the complexity of biological systems.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Spatial OMICS market was valued at USD 384.4 million in 2023 and is expected grow at 14.3% CAGR from 2024 – 2032, attributed to the increasing adoption of spatial genomics & transcriptomics and proteomics techniques in research and clinical applications.

The spatial transcriptomics segment accounted for USD 217.3 million, due to its ability to provide a comprehensive understanding of the spatial organization of gene expression within tissues.

North America spatial OMICS industry accounted for USD 167.7 million in 2023 and is anticipated to grow at 14.1% CAGR between 2024 – 2032, owing to well-established healthcare infrastructure and technological advancements in genomics and bioinformatics.

10x Genomics, Akoya Biosciences, Inc., Bio-Techne Corporation, BioSpyder, Inc., Bruker Corporation, Danaher Corporation, Diagenode Diagnostics (Hologic, Inc.), Ionpath, Inc., Millennium Science Pty Ltd., NanoString Technologies, Inc., PerkinElmer, Inc. and S2 Genomics, Inc.

Spatial OMICS Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 309
  • Countries covered: 22
  • Pages: 170
 Download Free Sample